Complementary information to the article: recommendations for management and follow-up in patients with transthyretin-mediated hereditary amyloidosis

dc.contributor.authorGina González-Robledo
dc.contributor.authorSandra Milena Castellar-Leones
dc.contributor.authorAndrés Díaz-Campos
dc.contributor.authorJorge Arturo Díaz Ruíz
dc.contributor.authorJennifer Garay
dc.contributor.authorGermán C. Giraldo-González
dc.contributor.authorMartha Gómez-Castro
dc.contributor.authorJuan David López‐Pónce de León
dc.contributor.authorErika M. Martínez-Carreño
dc.contributor.authorJairo H. Naranjo-Flóres
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T19:17:16Z
dc.date.available2026-03-22T19:17:16Z
dc.date.issued2024
dc.identifier.doi10.24875/rccare.m24000089
dc.identifier.urihttps://doi.org/10.24875/rccare.m24000089
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/75163
dc.language.isoen
dc.relation.ispartofRevista Colombiana de Cardiología (English Edition)
dc.sourceUniversidad de Los Andes
dc.subjectTransthyretin
dc.subjectAmyloidosis
dc.subjectMedicine
dc.subjectIntensive care medicine
dc.titleComplementary information to the article: recommendations for management and follow-up in patients with transthyretin-mediated hereditary amyloidosis
dc.typearticle

Files